182 related articles for article (PubMed ID: 14660719)
41. Influx rate of
Pitman KE; Alluri SR; Kristian A; Aarnes EK; Lyng H; Riss PJ; Malinen E
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2190-2198. PubMed ID: 31264167
[TBL] [Abstract][Full Text] [Related]
42. 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.
Spence AM; Muzi M; Mankoff DA; O'Sullivan SF; Link JM; Lewellen TK; Lewellen B; Pham P; Minoshima S; Swanson K; Krohn KA
J Nucl Med; 2004 Oct; 45(10):1653-9. PubMed ID: 15471829
[TBL] [Abstract][Full Text] [Related]
43. Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner.
Lodge MA; Badawi RD; Gilbert R; Dibos PE; Line BR
J Nucl Med; 2006 Jan; 47(1):23-31. PubMed ID: 16391183
[TBL] [Abstract][Full Text] [Related]
44. A lesion detection observer study comparing 2-dimensional versus fully 3-dimensional whole-body PET imaging protocols.
Lartizien C; Kinahan PE; Comtat C
J Nucl Med; 2004 Apr; 45(4):714-23. PubMed ID: 15073270
[TBL] [Abstract][Full Text] [Related]
45. Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imaging.
Williams JM; Arlinghaus LR; Rani SD; Shone MD; Abramson VG; Pendyala P; Chakravarthy AB; Gorge WJ; Knowland JG; Lattanze RK; Perrin SR; Scarantino CW; Townsend DW; Abramson RG; Yankeelov TE
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2374-2380. PubMed ID: 27557845
[TBL] [Abstract][Full Text] [Related]
46. 18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET.
Cobben DC; van der Laan BF; Maas B; Vaalburg W; Suurmeijer AJ; Hoekstra HJ; Jager PL; Elsinga PH
J Nucl Med; 2004 Feb; 45(2):226-31. PubMed ID: 14960640
[TBL] [Abstract][Full Text] [Related]
47. Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG.
Beer AJ; Lorenzen S; Metz S; Herrmann K; Watzlowik P; Wester HJ; Peschel C; Lordick F; Schwaiger M
J Nucl Med; 2008 Jan; 49(1):22-9. PubMed ID: 18077538
[TBL] [Abstract][Full Text] [Related]
48. Characterization of the normal adrenal gland with 18F-FDG PET/CT.
Bagheri B; Maurer AH; Cone L; Doss M; Adler L
J Nucl Med; 2004 Aug; 45(8):1340-3. PubMed ID: 15299059
[TBL] [Abstract][Full Text] [Related]
49. Relationship between 18F-FDG uptake and breast density in women with normal breast tissue.
Vranjesevic D; Schiepers C; Silverman DH; Quon A; Villalpando J; Dahlbom M; Phelps ME; Czernin J
J Nucl Med; 2003 Aug; 44(8):1238-42. PubMed ID: 12902413
[TBL] [Abstract][Full Text] [Related]
50. Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.
Henze M; Dimitrakopoulou-Strauss A; Milker-Zabel S; Schuhmacher J; Strauss LG; Doll J; Mäcke HR; Eisenhut M; Debus J; Haberkorn U
J Nucl Med; 2005 May; 46(5):763-9. PubMed ID: 15872348
[TBL] [Abstract][Full Text] [Related]
51. Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues.
Paquet N; Albert A; Foidart J; Hustinx R
J Nucl Med; 2004 May; 45(5):784-8. PubMed ID: 15136627
[TBL] [Abstract][Full Text] [Related]
52. 18F-FDOPA kinetics in brain tumors.
Schiepers C; Chen W; Cloughesy T; Dahlbom M; Huang SC
J Nucl Med; 2007 Oct; 48(10):1651-61. PubMed ID: 17873130
[TBL] [Abstract][Full Text] [Related]
53. Measurement of input functions in rodents: challenges and solutions.
Laforest R; Sharp TL; Engelbach JA; Fettig NM; Herrero P; Kim J; Lewis JS; Rowland DJ; Tai YC; Welch MJ
Nucl Med Biol; 2005 Oct; 32(7):679-85. PubMed ID: 16243642
[TBL] [Abstract][Full Text] [Related]
54. Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET.
Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Takekoshi N; Tonami N; Hisada K
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1357-64. PubMed ID: 12271419
[TBL] [Abstract][Full Text] [Related]
55. The impact of gene expression on 18F-FDG kinetics; a new chapter for diagnostic nuclear medicine.
Strauss LG; Dimitrakopoulou-Strauss A
Hell J Nucl Med; 2009; 12(1):2-4. PubMed ID: 19330172
[TBL] [Abstract][Full Text] [Related]
56. 1-11C-acetate kinetics of prostate cancer.
Schiepers C; Hoh CK; Nuyts J; Seltzer M; Wu C; Huang SC; Dahlbom M
J Nucl Med; 2008 Feb; 49(2):206-15. PubMed ID: 18199613
[TBL] [Abstract][Full Text] [Related]
57. Liver kinetics of glucose analogs measured in pigs by PET: importance of dual-input blood sampling.
Munk OL; Bass L; Roelsgaard K; Bender D; Hansen SB; Keiding S
J Nucl Med; 2001 May; 42(5):795-801. PubMed ID: 11337579
[TBL] [Abstract][Full Text] [Related]
58. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
[TBL] [Abstract][Full Text] [Related]
59. Analysis of FDG uptake with hybrid PET using standardised uptake values.
Zimny M; Kaiser HJ; Wildberger J; Nowak B; Cremerius U; Sabri O; Buell U
Eur J Nucl Med; 2001 May; 28(5):586-92. PubMed ID: 11383863
[TBL] [Abstract][Full Text] [Related]
60. An input function estimation method for FDG-PET human brain studies.
Guo H; Renaut RA; Chen K
Nucl Med Biol; 2007 Jul; 34(5):483-92. PubMed ID: 17591548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
